CoreComm Internet

Features

Make this your home page

Trump unveils deal with Regeneron to lower drug prices as part of most-favored-nation initiative

President Donald Trump on Thursday announced a deal with drugmaker Regeneron to lower the cost of its pharmaceutical products as part of the White House's signature drug pricing initiative. The deal involves Regeneron lowering the prices of current and all future drugs on Medicaid, according to Trump. It also involves selling a cholesterol drug called Praluent for $225 on the White House's discounted drug website TrumpRx, according to the agreement first outlined by NOTUS and confirmed by The...

Read More
 

----------
Copyright 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

CoreComm is not responsible for content on external sites. Please review the privacy and security policies of each vendor before making online purchases or providing personal information. Forecast Information Provided by AccuWeather.